TL;DR
This study investigated whether lobar or sublobar resection is a better surgical approach for early-stage second primary lung cancers (SPLC) up to 3 cm. While overall survival was similar between the two methods, lobar resection showed a survival advantage for SPLC tumors measuring 2-3 cm.
What Problem Does This Paper Address?
Multiple primary lung cancers (MPLC) are increasingly diagnosed, with a significant proportion being second primary lung cancers (SPLC). For these patients, the choice of surgical intervention for the SPLC is complex. Unlike primary lung cancer, patients with SPLC may have compromised pulmonary function and reserve due to prior surgery for their first primary lung cancer (FPLC). This can make more extensive surgeries, like lobectomy, riskier. Therefore, determining the optimal surgical strategy—whether a more conservative sublobar resection or a standard lobar resection—is crucial for balancing oncological outcomes with patient safety and quality of life. This paper aims to clarify this by comparing the overall survival (OS) of patients undergoing lobar versus sublobar resection for early-stage SPLC.
Methods
The researchers conducted a retrospective cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) database between 2004 and 2018. They focused on patients diagnosed with SPLC that was early-stage (T1-T2, ≤3 cm, node-negative) and who underwent a second surgery. To mitigate bias inherent in retrospective studies, they employed Propensity Score Matching (PSM) at a 1:1 ratio. This technique aimed to balance baseline characteristics between the lobar and sublobar resection groups, including factors like age, sex, FPLC characteristics (primary site, grade, type, size, stage, surgery), and SPLC characteristics (primary site, grade, type, size, stage, surgery), and whether the first and second surgeries were on the same side. The primary outcome was overall survival (OS), calculated from the SPLC diagnosis date to death or last follow-up. Subgroup analyses were performed to explore survival differences based on various patient and tumor characteristics.
Datasets
The study utilized the Surveillance, Epidemiology, and End Results (SEER) database, a comprehensive source of cancer incidence and survival data in the United States. The dataset included information on patients diagnosed with multiple primary malignant tumors between 2004 and 2018.
Key Insights and Ideas
- Sublobar resection is a viable option for many SPLC patients: The study suggests that for early-stage SPLC, sublobar resection can offer comparable survival outcomes to lobar resection, which is particularly important for patients with potentially compromised pulmonary function.
- Tumor size is a critical factor: The most significant finding is that tumor size appears to be a key determinant of the optimal surgical approach. While overall survival is similar for smaller tumors, larger SPLC tumors (2-3 cm) benefit more from lobar resection.
- PSM is crucial for reducing bias: The use of PSM was essential in this study to create comparable groups, allowing for a more reliable comparison of surgical outcomes and minimizing the influence of confounding factors.
Key Results
- Overall Survival: Before and after PSM, there was no statistically significant difference in overall survival (OS) between patients who underwent lobar resection and those who underwent sublobar resection for early-stage SPLC (P=0.289 before PSM, P=0.608 after PSM).
- Subgroup Analysis by Tumor Size:
- For SPLC tumors ≤2 cm, OS was similar between lobar and sublobar resection groups both before and after PSM.
- For SPLC tumors measuring 2-3 cm, lobar resection demonstrated a significantly better OS than sublobar resection, both before (P=0.046) and after PSM (P=0.013).
- Other Subgroup Analyses: No significant differences in OS were observed between lobar and sublobar resection in subgroups based on age, surgical modality of the first primary lung cancer, or the side of the first and second surgeries.
- Prognostic Factors: Multivariate Cox regression identified age (≥65 years), male sex, and squamous cell carcinoma of the first primary lung cancer as independent predictors of worse survival.
Limitations and Future Work
The authors acknowledge several limitations:
- Retrospective Design: The study's retrospective nature means that while PSM was used, unmeasured confounding factors could still influence the results.
- Lack of Data on Pulmonary Function and Comorbidities: Crucial data on cardiopulmonary performance, comorbidities, adjuvant chemotherapy, and targeted treatments were not available in the SEER database. This prevented a comprehensive analysis of how these factors might impact the surgical strategy and outcomes.
- Limited Data on Multiple Surgeries: The study focused on patients undergoing a second surgery and did not discuss outcomes for patients who had undergone three or more surgeries.
Future work should focus on prospective trials to validate these findings. Incorporating detailed clinical data, including pulmonary function tests and patient comorbidities, will be essential for individualizing surgical strategies for SPLC patients. Further research is also needed to explore the impact of the superposition of multiple surgeries on patient prognosis.
Summary updated